Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study.

OBJECTIVE To study the relationship of nonproliferative and proliferative retinopathy with all-cause mortality and cardiovascular disease (CVD) incidence in type 1 diabetic patients and, additionally, the role of cardiovascular risk factors in these associations. RESEARCH DESIGN AND METHODS This prospective study included 2,237 type 1 diabetic patients from 31 centers in 16 European countries at baseline, aged 15-60 years, who were examined for retinopathy by taking two-field 45 degrees fundus photographs, which were centrally graded. Mortality and cardiovascular morbidity follow-up was assessed 6-8 years after baseline examination according to a standardized protocol. RESULTS After 7.9 years of follow-up, 64 patients had died and 128 patients had incident CVD. The age- and sex-adjusted hazard ratios (HRs) of all-cause mortality were 1.45 (95% CI 0.71-2.96) and 4.16 (1.96-8.84) in patients with nonproliferative and proliferative retinopathy at baseline, respectively. Adjustments for cardiovascular risk factors completely obliterated the association with nonproliferative retinopathy, whereas the association with proliferative retinopathy remained twofold increased, although nonsignificant. The age- and sex-adjusted HRs of incident CVD were 1.73 (1.15-2.60) and 2.05 (1.22-3.45) in patients with nonproliferative and proliferative retinopathy, respectively. After adjustments for cardiovascular risk factors, both associations were attenuated and lost statistical significance. CONCLUSIONS This study shows that type 1 diabetic patients with nonproliferative or proliferative retinopathy have an increased risk for all-cause mortality and incident CVD. The presence of cardiovascular risk factors explained the associations to a large extent, except for the associations with proliferative retinopathy, which suggests that other shared mechanisms may be involved.

[1]  R. Klein,et al.  Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. , 2004, Archives of internal medicine.

[2]  N. Chaturvedi,et al.  Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. , 2004, Diabetes care.

[3]  Stephen J. Aldington,et al.  Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study , 1995, Diabetologia.

[4]  J. Stephenson,et al.  Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study , 1994, Diabetologia.

[5]  R. Busch,et al.  The antilipidemic effects of ezetimibe in patients with diabetes. , 2003, Diabetes care.

[6]  L. Bouter,et al.  Retinopathy is associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects: the hoorn study. , 2003, Diabetes care.

[7]  N. Chaturvedi,et al.  Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. , 2003, Diabetes care.

[8]  Giel Nijpels,et al.  Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. , 2003, Archives of ophthalmology.

[9]  Y. Ueki,et al.  Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[10]  R. Klein,et al.  The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. , 2002, Ophthalmology.

[11]  H. Parving,et al.  Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. , 2002, Diabetes.

[12]  R. Klein,et al.  The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study , 2002, The British journal of ophthalmology.

[13]  A. T. N. Group,et al.  Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes. , 2001, Diabetologia.

[14]  Stephen J. Aldington,et al.  Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. , 2001, Diabetes care.

[15]  A. Barden,et al.  Advanced Glycation End Products: A Review , 2013 .

[16]  S. Chakrabarti,et al.  Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy , 2000, Diabetes/metabolism research and reviews.

[17]  S. Keinänen-Kiukaanniemi,et al.  High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy. , 2000, Diabetes care.

[18]  L. Bouter,et al.  von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[19]  R. Klein,et al.  Association of ocular disease and mortality in a diabetic population. , 1999, Archives of ophthalmology.

[20]  R. Ross.  Atherosclerosis is an inflammatory disease , 1999 .

[21]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[22]  H. Gerstein,et al.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.

[23]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[24]  R. Weinshilboum,et al.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. , 1997, Archives of internal medicine.

[25]  M. Laakso,et al.  Retinopathy Predicts Coronary Heart Disease Events in NIDDM Patients , 1996, Diabetes Care.

[26]  M. Muggeo,et al.  Cardiovascular Disease and Its Risk Factors in IDDM in Europe , 1996, Diabetes Care.

[27]  A. Neil,et al.  A Prospective Population-Based Study of Microalbuminuria as a Predictor of Mortality in NIDDM , 1993, Diabetes Care.

[28]  W. G. John,et al.  Enzyme immunoassay--a new technique for estimating hemoglobin A1c. , 1993, Clinical chemistry.

[29]  D. Hewett‐Emmett,et al.  Mortality of Mexican Americans With NIDDM: Retinopathy and other predictors in Starr County, Texas , 1993, Diabetes Care.

[30]  D L DeMets,et al.  Relation of ocular and systemic factors to survival in diabetes. , 1989, Archives of internal medicine.

[31]  G. Watts,et al.  Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. , 1987, Journal of clinical pathology.

[32]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[33]  J. Albers,et al.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. , 1978, Journal of lipid research.

[34]  G Bucolo,et al.  Quantitative determination of serum triglycerides by the use of enzymes. , 1973, Clinical chemistry.

[35]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.